Investments, Acquisitions and Funding

The strategic manufacturing partnership with Queen St. Bakery will enable localized production of Eshbal’s bestselling gluten-free pita bread.

Operating the terminal under a lease gives CHS control over throughput and logistics without adding the facility to its balance sheet.

The new life sciences hub brings together Food & Nutrition, Pharmaceutical and Beauty & Personal Care to strengthen formulation, innovation and regulatory support.

ICL Group is acquiring Bartek Ingredients in a two-phase deal, starting with US$90 million for 50% stake in Q1 2026.

UNOX Group targets €400 Million (US$465.84M) revenue from the acquisition by 2026.